Get complete Patent Opposition Report for Ellodi Pharmaceuticals

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore patent oppositions filed by Ellodi Pharmaceuticals against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP2886108Optimised Pharmaceutical Formula For The Treatment Of Inflammatory Changes Of The EsophagusDR FALK PHARMANov 6, 2019
EP3086782Optimized Pharmaceutical Formulation For The Treatment Of Inflammatory Conditions Of The EsophagusDR FALK PHARMAJun 26, 2019

Explore Ellodi Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3041476Jan 25, 2023Corticosteroid Containing Orally Disintegrating Tablet Compositions For Eosinophilic Esophagitis1
EP3403654Jul 31, 2019Orally Administered Corticosteroid Compositions1
EP2482822Aug 1, 2018Orally Administered Corticosteroid Compositions1